Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the nationwide availability of Agilent Technologies' PD-L1 IHC 22C3 pharmDx, the only companion ...

LH heads into Q1 earnings results with rising diagnostics demand, new partnerships, and AI-driven tools boosting growth ...

Labcorp is a global life sciences company headquartered in Burlington, North Carolina. Labcorp provides at-home test kits as well as in-person testing at their laboratory facilities, which are located ...

Labcorp is expanding its collaboration with PathAI to deploy the FDA-cleared AISight Dx digital pathology platform across its national network of labs and hospital partners. The cloud-based system ...

The yet-to-be-named new company will be publicly traded. Separating the laboratory testing work of LabCorp from the clinical trial services business, much of which came from acquisitions, will enable ...

The deal includes outreach laboratory services in 13 states. CHS will continue to operate its inpatient and emergency department labs along with other hospital-based testing services. Like its chief ...

North Carolina-based LabCorp Diagnostics, one of the largest clinical laboratories in the U.S., was forced to shut down its network on Sunday after officials detected suspicious activity, according to ...

Optum.ai and Labcorp have announced a strategic collaboration to apply artificial intelligence to streamline laboratory operations, improve efficiency, and enhance patient and provider experiences.

A large regional health system has saved more than $5 million a year on labor and supplies—and even more with capital expense avoidance—by partnering with Labcorp. Within a period of one year, Labcorp ...

While the spinoff deal is positive for Labcorp, investors used the opportunity to sell on the news. Labcorp will do a $1 billion stock repurchase program and pay down debt. The company's revenues have ...

Labcorp introduces US FDA-approved companion diagnostic to identify patients with ovarian cancer eligible for Keytruda: Burlington, North Carolina Friday, April 24, 2026, 13:00 Hr ...